EP1411895A2 - ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PRINCIPLE CAPABLE OF BEING SUBJECTED TO HIGH EFFECT DURING ITS FIRST PASSAGE THROUGH THE INTESTINE